Anavex Life Sciences Corp (AVXL)

[TempePhil]

Red, I like to compare Anavex drugs, to the competition, whenever possible.
If I ever see Anavex being beaten, I will be VERY concerned.

I am not so quick to discount Lilly. I think they have much better efficacy data than Biogen, and even Biogen has managed to keep their drug moving forward.

Yes, Lilly definitely has safety issues, as you mentioned (I had them in my original chart post as well). I do not remember the Biogen safety severities or percentages. Might make an interesting comparison.

I think we are ahead of Lilly time-wise. Our Alz should read out mid next year.

The sad thing about the these other big Alz trials, is that they compete and remove patients from possible Anavex trials. Biogen trials are huge, and they do not think twice about adding patients.

Regarding beating the dead horse, several people corrected some of my wording, so that is helpful. Questions arise because of communication issues, no arguing that!!